Table 1.
Higher-valent combination vaccines (MMR + & DTP +) covered by the National Immunization Programs in China and selected countries
| Country | Tetravalent vaccines | Pentavalent vaccines | Hexavalent vaccines |
|---|---|---|---|
| China | – | – | – |
| U.S. |
DTaP-IPV MMR |
DTaP-IPV-Hib DTaP-IPV-HepB |
DTaP-HepB-IPV-Hib |
| U.K. | DTaP-IPV | – | DTaP-HepB-IPV-Hib |
| Germany | MMR | – | DTaP-HepB-IPV-Hib |
| Singapore | – | DTaP-IPV-Hib | – |
| Malaysia | – | – | DTaP-HepB-IPV-Hib |
| Brazil | – | DTwP-Hib-HepB | – |
| Cambodia (GAVI-supported) | – | DTwP-Hib-HepB | – |
– means not applicable
DTaP-IPV Diphtheria, tetanus, acellular pertussis, and polio; MMR Measles, mumps, and rubella; DTaP-Hib Diphtheria, tetanus, acellular pertussis, and Haemophilus influenzae type b; DTaP-IPV-HepB Diphtheria, tetanus, acellular pertussis, polio and hepatitis B; DTaP-HepB-IPV-Hib Diphtheria, tetanus, acellular pertussis, hepatitis B, polio, and Haemophilus influenzae type b; DTwP-Hib-HepB Diphtheria, tetanus, whole cell pertussis, Haemophilus influenzae type b, and hepatitis B